ReviewThe Journal of clinical investigation2023

Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target.

Feyza Gul Ozbay Kurt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.